Literature DB >> 9630161

No increase in blood-brain barrier permeability after intraperitoneal injection of endotoxin in the rat.

U Bickel1, B Grave, Y S Kang, A del Rey, K Voigt.   

Abstract

Reactions mediated by the brain are part of the response to intraperitoneal administration of endotoxin, a model of gram-negative bacterial infection. To test the hypothesis that a compromised blood-brain barrier (BBB) may contribute to these reactions, the integrity of the BBB was measured following lipopolysaccharide administration. Rats received intraperitoneal injections of 50 microg/kg or 2 mg/kg of endotoxin. Brain uptake of a macromolecular vascular marker, 3H-labelled rat serum albumin, and of a poorly permeable low molecular weight substance, [14C]sucrose, was then measured with the intravenous bolus injection method. Compared to controls, neither dose of endotoxin affected the BBB permeability for these tracers. This was true when brain uptake was measured 5 min or 2 h after lipopolysaccharide injection. It is concluded that intraperitoneal endotoxin even at a high dose does not acutely disrupt the BBB.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9630161     DOI: 10.1016/s0165-5728(98)00004-6

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  9 in total

1.  Effects of hepatic ischemia-reperfusion injury on the blood-brain barrier permeability to [14C] and [13C]sucrose.

Authors:  Mohammad K Miah; Ulrich Bickel; Reza Mehvar
Journal:  Metab Brain Dis       Date:  2017-08-04       Impact factor: 3.584

2.  Coadministration of branched-chain amino acids and lipopolysaccharide causes matrix metalloproteinase activation and blood-brain barrier breakdown.

Authors:  Giselli Scaini; Meline O S Morais; Leticia S Galant; Francieli Vuolo; Dhébora M Dall'Igna; Matheus A B Pasquali; Vitor M Ramos; Daniel P Gelain; Jose Claudio F Moreira; Patrícia F Schuck; Gustavo C Ferreira; Francisco G Soriano; Felipe Dal-Pizzol; Emilio L Streck
Journal:  Mol Neurobiol       Date:  2014-01-05       Impact factor: 5.590

3.  Chronic systemic endotoxin exposure: an animal model in experimental hepatic encephalopathy.

Authors:  Kai O Lindros; Harri A Järveläinen
Journal:  Metab Brain Dis       Date:  2005-12       Impact factor: 3.584

Review 4.  Cerebral blood flow in acute liver failure: a finding in search of a mechanism.

Authors:  Javier Vaquero; Chuhan Chung; Andres T Blei
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

Review 5.  Parkinson's disease and enhanced inflammatory response.

Authors:  Iva Stojkovska; Brandon M Wagner; Brad E Morrison
Journal:  Exp Biol Med (Maywood)       Date:  2015-03-13

6.  Anti-Tumor Necrosis Factor Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel Disease.

Authors:  Inga Peter; Marla Dubinsky; Susan Bressman; Andrew Park; Changyue Lu; Naijun Chen; Anthony Wang
Journal:  JAMA Neurol       Date:  2018-08-01       Impact factor: 18.302

Review 7.  Methods used for the measurement of blood-brain barrier integrity.

Authors:  Huixin Sun; Huiling Hu; Chuanjie Liu; Nannan Sun; Chaohui Duan
Journal:  Metab Brain Dis       Date:  2021-02-26       Impact factor: 3.584

8.  Lipopolysaccharide animal models for Parkinson's disease.

Authors:  Mei Liu; Guoying Bing
Journal:  Parkinsons Dis       Date:  2011-04-27

9.  Re-exposure to endotoxin induces differential cytokine gene expression in the rat hypothalamus and spleen.

Authors:  Adriana del Rey; Anke Randolf; Johannes Wildmann; Hugo O Besedovsky; David S Jessop
Journal:  Brain Behav Immun       Date:  2009-02-28       Impact factor: 7.217

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.